AtriCure (ATRC) Tops Q1 EPS by 3c, Reiterates Prior Guidance For FY 2017
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $44.30 +1.86%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $41.3 million versus the consensus estimate of $40.3 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Movano (MOVE) Misses Q2 EPS by 195c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
